Overall, our results, and that of others, point toward a tumor type-dependent function of SAMHD1 in cancer onset and/or progression, reflecting once more the great heterogeneity of cancer biology, which deeply challenges the drive for personalized treatment. This evidence concerns the gene SAMHD1 and cancer.